Xcout Intel
Camurus competitors & alternatives
The 12 closest competitors and alternatives to Camurus among pharmaceuticals (drug delivery) companies — ranked by similarity to what Camurus actually does, not by market-cap band.
Subscribe to see Camurus’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Camurus
Camurus is an international pharmaceutical company that develops and provides innovative, long-acting treatments for patients with severe and chronic conditions. The company focuses on therapeutic areas including the central nervous system, rare diseases, endocrinology, oncology, and supportive care.
Camurus at a glance
Camurus is a pharmaceuticals (drug delivery) company headquartered in Sweden. Xcout tracks 8 named people at Camurus, including Fredrik Tiberg (President & Chief Executive Officer).
Camurus leadership
- Fredrik TibergPresident & Chief Executive Officer
- Per Olof WallströmChairman
- Elisabeth BjorkBoard member
- Erika Söderberg JohnssonBoard Member
- Hege HellstromBoard member
- Jakob LindbergBoard member
2 more named people on record for Camurus, with roles, board committees and tenure — see the full roster →
Top 12 Camurus competitors
Ranked by semantic similarity — how close each company is to Camurus by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Pharmaceuticals
Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.
Pharmaceuticals
Orexo AB is a pharmaceutical company that specializes in developing innovative drug delivery technologies, notably its powder-based AmorphOX platform. The company advances proprietary and partnered pharmaceutical products, including treatments, vaccines, and nasal delivery formulations, serving patients and healthcare partners globally.
Pharmaceuticals
Grünenthal is a global pharmaceutical company that researches, develops, and commercializes innovative treatments and medicines with a primary focus on pain management and related diseases. Operating as a science-based business, the company serves patients worldwide by delivering therapies for conditions such as chronic pain, rare diseases, and neurobiological indications.
Pharmaceuticals
Purpose Pharma International AB is a European pharmaceutical company headquartered in Stockholm, Sweden. The firm is dedicated to giving people with rare diseases a better quality of life.
Biotech, Pharma
Mendus is a pharmaceutical company based in Sweden and the Netherlands that is dedicated to changing the course of cancer treatment by addressing tumor recurrence.
Pharmaceuticals
Curatis Holding AG specializes in the entire lifecycle of pharmaceutical products, including the procurement, advancement, and market release of medications specifically designed for the diagnosis, prevention, and management of rare and specialized medical conditions. The company's extensive product offerings span a broad array of therapeutic areas. These encompass treatments for antiplatelet conditions, metastatic hormone receptor-positive breast cancer, anti-arrhythmic disorders, nasal oil applications, Wilson's disease, antidotes for cyanide poisoning and digoxin toxicity, antihypotensive agents, therapies for bladder pain syndrome/interstitial cystitis, antibiotics, diagnostic tools for ophthalmology, antivirals, ophthalmic/antibiotic combinations, gentamycin collagen sponges, solutions for benign prostatic hyperplasia, immunomodulators, treatments for epilepsy and essential tremor, thyreostatics, therapies for hereditary tyrosinemia type 1, gastroenterological products, additional immunomodulators and thyreostatics, tranquilizers, Helicobacter pylori tests, phosphate binders, specialized nutritional support for dialysis patients, dermatological corticosteroids, antidotes for lead and mercury poisoning, corticostimulants, anti-fog agents, treatments for chorea associated with Huntington's disease, and antiepileptics. In addition to its commercialized portfolio, Curatis is actively engaged in developing new pharmaceutical compounds. Its pipeline includes C-PTBE-01, currently in Phase IIb clinical trials for treating peritumoral brain edema in pediatric patients; C-AM-01, undergoing Phase IIa trials for preventing severe migraine with aura; and C-MOH-01, also in Phase IIa for the treatment and prevention of medication overuse headache. Furthermore, KIN001 is in Phase I clinical trials, targeting rare inflammatory and fibrotic diseases. The company maintains its headquarters in Liestal, Switzerland.
Pharmaceuticals
Egetis Therapeutics is a Swedish specialty pharmaceutical company headquartered in Stockholm that focuses on developing and commercializing treatments for serious rare diseases.
Pharmaceuticals
Servier is an international pharmaceutical company that researches, develops, and provides medical treatments primarily focused on oncology, cardio-metabolic diseases, and neurology. The company serves patients globally by delivering therapeutic innovations and advancing research in areas such as rare diseases and chronic conditions.
Pharmaceuticals
Braeburn Inc. is a pharmaceutical company that develops, manufactures, and commercializes medications for central nervous system disorders, with a primary focus on delivering solutions for opioid addiction and use disorder.
Pharmaceuticals
Recordati is a global pharmaceutical company that develops and commercializes medicines for both common and rare diseases. It serves patients across approximately 150 countries through its specialty, primary care, and rare diseases operations.
Pharmaceuticals
Hyloris is a specialty biopharma company committed to addressing unmet medical needs through the development of pharmaceutical products and drug delivery solutions. It serves patients and healthcare providers by bringing innovative therapeutic options to the market.
Pharmaceuticals
Lavipharm is an international healthcare company that researches, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and food supplements. The company primarily serves healthcare professionals and patients by providing treatment options in areas such as cardiology, neurology, urology, oncology, and chronic pain.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Camurus and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Camurusand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →